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Abstract. 
 
Caspases are an extended family of cysteine 
proteases that play critical roles in apoptosis. Animals 
deﬁcient in caspases-2 or -3, which share very similar 
tetrapeptide cleavage speciﬁcities, exhibit very different 
phenotypes, suggesting that the unique features of indi-
vidual caspases may account for distinct regulation and 
specialized functions. Recent studies demonstrate that 
unique apoptotic stimuli are transduced by distinct pro-
teolytic pathways, with multiple components of the pro-
teolytic machinery clustering at distinct subcellular 
sites. We demonstrate here that, in addition to its nu-
clear distribution, caspase-2 is localized to the Golgi 
complex, where it cleaves golgin-160 at a unique site 
not susceptible to cleavage by other caspases with very 
similar tetrapeptide speciﬁcities. Early cleavage at this 
site precedes cleavage at distal sites by other caspases. 
Prevention of cleavage at the unique caspase-2 site de-
lays disintegration of the Golgi complex after delivery 
of a pro-apoptotic signal. We propose that the Golgi 
complex, like mitochondria, senses and integrates 
unique local conditions, and transduces pro-apoptotic 
signals through local caspases, which regulate local ef-
fectors.
Key words: signaling • subcellular • substrate • coiled 
coil • protease
 
Introduction
 
Apoptosis is a highly regulated form of cell suicide that
can be triggered by a variety of internal or external signals
(for reviews see Ashkenazi and Dixit, 1998; Thornberry
and Lazebnik, 1998). Caspases, a highly conserved family
of cysteine proteases, play a critical role in apoptosis by
participating in a cascade of cleavage events that result in
the apoptotic phenotype. These proteases are synthesized
as inactive proenzymes, which are cleaved at Asp-X sites
during apoptosis, generating large and small subunits that
heterodimerize to form the active enzyme. On the basis of
substrate specificities, members of the caspase family can
be grouped into three subfamilies: (1) group I caspases,
consisting of caspases-1, -4, and -5; (2) group II caspases,
consisting of caspases-2, -3, and -7; and (3) group III
caspases, consisting of caspases-6, -8, -9, and -10 (Thorn-
berry et al., 1997). The optimal substrate sequences for
group III caspases resemble the cleavage sites used in sev-
eral caspase proenzymes, suggesting that these proteases
are the upstream components in a caspase-driven pro-
teolytic cascade. The optimal recognition motif for group
II caspases (DEXD) is similar to the cleavage sites of sev-
eral downstream substrates that are cleaved during apop-
tosis, suggesting that members of this family act as down-
stream effectors of apoptosis. Proapoptotic caspases can
also be grouped according to their primary structure, with
 
caspases-2, -8, -9, and -10, containing long NH
 
2
 
-termi-
nal  prodomains, and caspases-3, -6, and -7, containing
short prodomains. The long prodomains of initiator cas-
pases serve a critical function in inducing dimerization and
activation of caspase precursors, through interactions
with similar domains in adaptor molecules (e.g., FADD,
RAIDD, and Apaf-1; Muzio et al., 1996; Butt et al., 1998;
Martin et al., 1998; Yang et al., 1998). In contrast, short
prodomain caspases function as downstream effectors of
apoptosis, which are activated when their precursors are
cleaved by upstream caspases.
Despite extensive homology and similar substrate speci-
ficities among caspase subfamily members, distinct pheno-
types of caspase-deficient mice demonstrate that different
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group II caspases contribute to apoptosis in a tissue and
stimulus-specific manner (for reviews see Li and Yuan,
1999; Los et al., 1999; Zheng et al., 1999). For example,
caspase-2 (Nedd2/Ich-1) null mice develop normally but
accumulate excess numbers of oocytes that are resistant to
apoptosis induced by chemotherapeutic agents (Bergeron
et al., 1998). In contrast, caspase-3 null mice have severe
abnormalities limited to the brain, with enlarged brain,
skull defects, and excess accumulation of neurons (Kuida
et al., 1996; Woo et al., 1998). These unique phenotypes
suggest that similar caspases have unique biochemical and
cell biological properties, which transduce different apop-
totic signals. In this regard, recent studies have dem-
onstrated that distinct apoptotic pathways are initiated in
distinct subcellular domains. For example, numerous com-
ponents in the cytochrome 
 
c
 
/Apaf-1/caspase-9/caspase-3
pathway are enriched in and around mitochondria (Liu
et al., 1996; Kluck et al., 1997; Mancini et al., 1998; Samali
et al., 1998; Krajewski et al., 1999; Krebs et al., 1999;
Susin et al., 1999), while ligation of death receptors at the
cell surface induces formation of a signaling complex that
includes receptors, adaptors, and different upstream cas-
pases (for review see Ashkenazi and Dixit, 1998).
Caspase-2 is unique among the caspases in that it has
features of both upstream caspases (a long prodomain)
and downstream caspases (DEXD substrate specificity).
The prodomain of caspase-2 has been shown to be essen-
tial for the dimerization and autoprocessing of precursor
caspase-2 molecules (Butt et al., 1998). This caspase-2 pro-
domain also interacts with a homologous domain in the
death adaptor protein RAIDD, thus, implicating caspase-2
as an upstream activator of a distinct caspase pathway
(Duan and Dixit, 1997). Whether caspase-2 is transducing
pro-apoptotic signals from a unique subcellular domain is
presently unknown. While GFP fusion constructs have
localized caspase-2 to the cytoplasm and nucleus, the lo-
calization of the endogenous protease has not yet been de-
termined (Colussi et al., 1998). Furthermore, despite sig-
nificant evidence for the participation of caspase-2 in some
apoptotic pathways (Kumar et al., 1994; Wang et al., 1994;
Kumar, 1995; Harvey et al., 1997; Li et al., 1997; Troy et
al., 1997; Chen et al., 1999), no downstream substrates for
this protease have yet been identified.
In the present study, we demonstrate that endogenous
caspase-2 is localized predominantly to the Golgi complex
and the nucleus. In addition, we identify golgin-160 as a
Golgi-localized macromolecular substrate for caspase-2,
and demonstrate its cleavage by caspase-2 during apopto-
sis. We propose that the Golgi complex transduces pro-
apoptotic signals through caspase-2.
 
Materials and Methods
 
Antibodies Recognizing Caspase-2
 
Rabbit polyclonal antibodies to the large subunit of caspase-2 (MetAsn
 
150
 
-
Thr
 
435
 
) were generated as described previously (Mancini et al., 1998) and
called MF386 and MF388. The specificity of these antisera for caspase-2
was demonstrated as follows. When purified, recombinant large subunits
of caspases-1–10 (excluding caspase-6) were immunoblotted with MF386
or MF388; only the large subunit of caspase-2 was recognized (data not
shown). (b) Both MF386 and MF388 (but not preimmune sera) immuno-
precipitated caspase-2 precursor from [
 
35
 
S]Met-labeled HeLa cells or gen-
erated by in vitro transcription/translation (IVTT;
 
1
 
 data not shown).
MF386 and MF388 were affinity-purified against purified, recombinant
p18 subunit of caspase-2 as described (Mancini et al., 1998). Anti–cas-
pase-2 antibody sc623 and its corresponding blocking peptide were pur-
chased from Santa Cruz Biotechnology, Inc. Anti-ICH-1
 
L
 
 was purchased
from Transduction Laboratories.
 
Antibodies Recognizing Golgin-160
 
The peptides DGASAEQDGLQEDRC (comprising the first 14 amino
acids of golgin-160 after the initial Met plus a COOH-terminal Cys) and
MLDQEAAFMQIQEAC (comprising amino acids 649–662, plus a
COOH-terminal Cys) were synthesized and conjugated to KLH (Boston
Biomolecules, Inc.). These peptides were named golgin-160(N) and gol-
gin-160(648), respectively, and used to immunize several rabbits to gener-
ate anti–golgin-160 antisera (Covance Research Products). Specificity of
both antisera for golgin-160 was confirmed by immunofluorescence, im-
munoblotting, and immunoprecipitation of in vitro translated golgin-160
(data not shown).
 
Immunofluorescence Microscopy
 
Immunofluorescence was performed on coverslips that were fixed with
4% paraformaldehyde and permeabilized with acetone exactly as previ-
ously described (Mancini et al., 1998; except for anti–ICH-1
 
L
 
 staining and
golgin-160 stable lines; see below). Cells were incubated with 5 
 
m
 
g/ml of
affinity-purified MF386 or MF388, 3 
 
m
 
g/ml of sc623, or anti–golgin-160(N)
antiserum (1:2,500; for 20 min at 4
 
8
 
C), followed by biotin-conjugated goat
anti–rabbit IgG (for 20 min at room temperature; Organon Teknika
Corp.) and Texas red–conjugated streptavidin (for 10 min at room tem-
perature; Molecular Probes). When performing double labeling, cells
were stained first with mouse monoclonal antigiantin (for 20 min at 4
 
8
 
C;
provided by Hans-Peter Hauri, University of Basel, Switzerland), fol-
lowed by incubation with fluorescein-conjugated goat anti–mouse IgG
(for 20 min at room temperature; Jackson ImmunoResearch Laborato-
ries, Inc.), and subsequently with 2% goat serum (for 20 min at 4
 
8
 
C). Cells
were stained with anti–caspase-2 or anti–golgin-160 antibodies (as de-
scribed above).
The anti-ICH-1
 
L
 
 antibody (Transduction Labs) did not react with its
epitope unless permeabilization was performed concomitant with fixation.
HeLa cells stably expressing EGFP-golgin-160 (see below) were fixed in
4% paraformaldehyde containing 0.18% Triton X-100 for 10 min at room
temperature, and stained with rabbit anti-GFP (Molecular Probes, Inc.)
and mouse anti–ICH-1
 
L
 
, followed by fluorescein-conjugated goat anti–
rabbit IgG and Texas red goat anti–mouse IgG (both from Jackson Immu-
noResearch Laboratories, Inc.).
When specified, nuclei were visualized by labeling with 4
 
9
 
,6-diamidino-
2-phenylindole (DAPI) (Molecular Probes, Inc.). In all cases, coverslips
were mounted on glass slides with PermaFluor (Lipshaw), and confocal
microscopy was performed on a scanning confocal microscope system
(model LSM 410; Carl Zeiss, Inc.).
The specificity of caspase-2 staining was confirmed as follows. Affinity-
purified MF386 was preincubated with 100-fold excess of its cognate p18
antigen or with an irrelevant large caspase subunit antigen (caspase-9),
and staining was performed on HeLa cells using this preabsorbed antise-
rum. Nuclear and Golgi staining were completely abolished by preabsorp-
tion with cognate caspase-2 antigen, whereas nuclear and Golgi staining
were not affected by incubation with the caspase-9 large subunit (data not
shown). Similarly, preabsorption of sc623 with its cognate peptide com-
pletely abolished nuclear and Golgi-associated staining (data not shown).
(b) No nuclear or Golgi staining was observed when cells were stained
with preimmune sera (data not shown). (c) Staining performed with 11
other affinity-purified antibodies to caspases-3, -4, -5, -7, -9, and -10 failed
to demonstrate Golgi staining (data not shown).
The EGFP-golgin-160 stable lines were fixed with 3% paraformalde-
hyde for 10 min, permeabilized with 0.5% Triton X-100 for 3 min, and la-
beled with mouse anti-GM130 (Transduction Labs) and rabbit anti-GFP,
followed by Texas red goat anti–mouse and fluorescein-conjugated goat
anti–rabbit IgG.
 
1
 
Abbreviations used in this paper:
 
 DAPI, 4
 
9
 
,6-diamidino-2-phenylindole;
GFP, green fluorescent protein; IVTT, in vitro transcription/translation. 
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Cell Lines and Induction of Apoptosis
 
HeLa cells were passaged in 10% heat-inactivated calf serum using stan-
dard tissue culture procedures. Human keratinocytes were obtained from
neonatal foreskins and cultured as described (Casciola-Rosen et al., 1995).
The human salivary gland cell line was a gift of Dr. Bruce Baum (National
Institutes of Health, Bethesda, MD). Apoptosis was induced by irradia-
tion with UVB (Casciola-Rosen et al., 1994) or treatment with 1 
 
m
 
M stau-
rosporine (Jacobson et al., 1996).
 
Western Blotting
 
Collection and lysis of adherent and nonadherent cells, electrophoresis,
transfer to nitrocellulose, and immunoblotting were performed as previ-
ously described (Casciola-Rosen et al., 1995). The densities of bands on
autoradiograms were determined on a PDI Discovery densitometry sys-
tem using Quantity One software (Bio-Rad Laboratories).
 
Cloning of Golgin-160
 
A cDNA clone corresponding to the open reading frame of golgin-160
and flanked by XbaI sites was generated by reverse transcriptase–PCR
from human liver and subcloned into the XbaI site of pBlueScript SK
 
1
 
.
The cDNA clone was sequenced in its entirety by dideoxy sequencing,
and was identical to the published sequence with the exception of the fol-
lowing amino acid substitutions which for the most part were conservative
substitutions: I
 
609
 
L, H
 
746
 
R, M
 
932
 
V, K
 
1017
 
R, V
 
1281
 
A, R
 
1315
 
W. More impor-
tantly, our cDNA clone contained a 5-bp insertion immediately after
amino acid 1,377 that created a frameshift, resulting in a COOH-terminal
tail that was 32 amino acids shorter and nonidentical to the published gol-
gin-160 sequence (Misumi et al., 1997). We do not believe that the 5-bp in-
sertion was introduced while amplifying the cDNA clone by PCR, as the
identical 5-bp insertion is present in a human EST sequence (AL044812)
and in the mouse Mea-2 protein (Kondo and Sutuo, 1997). Mutagenesis of
golgin-160 was carried out using the PCR-based QuikChange site-directed
mutagenesis kit (Stratagene), and the mutations were confirmed by
dideoxy sequencing.
 
In Vitro Cleavage of [
 
35
 
S]Methionine-labeled 
Substrates Generated by In
Vitro Transcription/Translation
 
[
 
35
 
S]methionine-labeled golgin-160 and golgin-160 mutants were gener-
ated by coupled in vitro transcription/translation (Casciola-Rosen et al.,
1996). Cleavage reactions with caspases-3 and -7 were performed in buffer
A consisting of 50 mM Hepes, pH 7.4, 10% sucrose, 0.1% CHAPS, and 5
mM DTT. Reactions with caspase-3 contained 0.74 nM caspase-3, and
those with caspase-7 contained 2.5 nM caspase-7. Cleavage reactions with
40 nM caspase-2 were performed in buffer B consisting of 0.1 M Mes, 10%
PEG, 0.1% CHAPS, pH 5.5, and 5 mM DTT (Garcia-Calvo et al., 1999).
After incubating samples at 37
 
8
 
C for 60 min, reactions were terminated by
the addition of gel buffer and boiling, and samples were electrophoresed
on 7.5% SDS-PAGE. Intact proteins and their fragments were visualized
by fluorography. Catalytic constant values were determined as described
in Casciola-Rosen et al. (1999) according to the formula:
 
GFP Tagging of Golgin-160
 
A 350-bp segment corresponding to the 5
 
9
 
 end of the golgin-160 coding re-
gion was amplified by PCR, to introduce a 5
 
9
 
 XhoI site in-frame with the
COOH terminus of GFP in the vector pEGFP-C1 (CLONTECH Labora-
tories, Inc.), and was digested with XhoI and SpeI. The full-length coding
region of golgin-160 with the new 5
 
9
 
 XhoI site was subcloned into the
XhoI and BamH1 sites of pEGFP-C1. The amplified region was verified
by DNA sequence analysis. HeLa cells (4 
 
3
 
 10
 
6
 
) were transfected with 10
 
m
 
g pEGFP-golgin-160 or pEGFP-golgin-160(D59A) using Lipofectamine
(Life Technologies, Inc.) following the manufacturer’s directions. After
selection in G418, individual G418–resistant colonies were expanded and
screened for green fluorescent protein (GFP) fluorescence. One colony
from each transfection was fully characterized for expression of the GFP
fusion protein and used in experiments described below.
percent substrate cleavage 100 1 e
k – cat E []Km ¤ ´ time ´
– () ´ . =
 
In Vivo Apoptosis Experiments with GFP-golgin-160 
Stable Cell Lines
 
Stable cell lines expressing EGFP-golgin-160 and EGFP-golgin-160
(D59A) were plated, and when they were 
 
z
 
90% confluent, they were
treated with 10 mM sodium butyrate in normal growth medium for 12–15 h
to increase the expression of the GFP fusion protein. In experiments
where antigen detection was by immunoblotting, cells were treated with 1
 
m
 
M staurosporine or left untreated for the times indicated, lysed, and pro-
cessed as described (Casciola-Rosen et al., 1995). In those experiments
where detection was by immunoprecipitation, cells were labeled with 100
 
m
 
Ci 
 
35
 
S-Promix (Amersham Pharmacia Biotech, Inc.) in methionine- and
cysteine-free DME for 60 min at 37
 
8
 
C, followed by a chase in regular
growth medium for 8 h in the presence or absence of 1 
 
m
 
M staurosporine
as indicated. Cells were lysed and immunoprecipitated as described
(Weisz et al., 1993), using rabbit anti-GFP serum (0.5 
 
m
 
l per sample; Mo-
lecular Probes, Inc.) overnight at 4
 
8
 
C. Immunocomplexes were collected
with Pansorbin (Calbiochem), washed, electrophoresed on 10% SDS-
PAGE, and visualized by fluorography.
To assess Golgi disassembly during apoptosis, stable lines plated on
coverslips expressing wt or D59A EGFP-golgin-160 were untreated or
treated with 1 
 
m
 
M staurosporine for 2.5 h. Cells were fixed, permeabilized,
and labeled with rabbit anti-GFP and FITC-conjugated secondary anti-
bodies as described above. The Golgi morphology of expressing cells was
analyzed and categorized as intact or scattered. This quantitation was per-
formed by three individuals on two different experiments. Results are pre-
sented as the mean 
 
6
 
 SD.
 
Results
 
Caspase-2 Has a Nuclear and Golgi Localization
 
The subcellular localization of caspase-2 was determined
by confocal immunofluorescence microscopy in HeLa
cells using affinity-purified rabbit antibodies recognizing
the large subunit of caspase-2 (MF386, MF388). Caspase-2
had a nuclear staining pattern, as well as a distinct juxtanu-
clear, reticular pattern that appeared Golgi-like (Fig. 1 a).
This juxtanuclear component colocalized with giantin, a
370-kD integral Golgi membrane protein that has most of
its mass facing the cytoplasm (Linstedt and Hauri, 1993;
Seelig et al., 1994; Fig. 1, b and c). Similar Golgi staining
was observed with the anti–caspase-2 antibodies after se-
lective permeabilization of the plasma membrane with
digitonin, suggesting that caspase-2 is associated with the
cytoplasmic face of Golgi membranes (data not shown).
Nuclear and Golgi staining was also obtained with two
commercially available anti–caspase-2 antibodies: sc623,
raised against an NH
 
2
 
-terminal peptide of caspase-2, and
anti-ICH-1
 
L
 
, an mAb raised against residues 225–401 of
caspase-2 (Fig. 1, d–i). An identical staining pattern was
observed in several other cell types, including human kera-
tinocytes and human salivary gland cells (data not shown).
In preliminary subcellular fractionation experiments, 35%
of the total caspase-2 was present in the nuclear fraction,
10% pelleted with the membrane, and the remainder was
found in the cytosol fraction (data not shown). It is not
clear if the large cytosolic pool of caspase-2 is real, or dis-
sociates from the membranes or nuclei during fraction-
ation. Although caspase-2 exists in two splicing isoforms
(Wang et al., 1994), we were unable to detect any of the
short isoform in HeLa cells by immunoblotting or immu-
noprecipitation (data not shown).
 
Golgin-160 Is Cleaved during Apoptosis
 
Since caspase-2 localized to the Golgi, we investigated 
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whether caspase-2 substrates are also located at this sub-
cellular site. We focused our search on several Golgi au-
toantigens targeted in patients with systemic autoimmune
diseases because proteins cleaved by caspases during apop-
tosis are frequently targeted as autoantigens (Casciola-
Rosen et al., 1995, 1996; Casiano et al., 1996; Rosen and
Casciola-Rosen, 1999). These autoantigens are members
of a protein family called golgins, which possess large
coiled-coil domains. Some family members have been im-
plicated in Golgi structure and membrane traffic (for re-
view see Chan and Fritzler, 1998). Using an antibody rec-
ognizing golgin-160, we immunoblotted lysates of control
or apoptotic HeLa cells, in which apoptosis was induced
by staurosporine (Fig. 2) or UVB irradiation (data not
shown). Golgin-160 was cleaved to generate a 140-kD
fragment in early apoptotic cells, as well as a less promi-
nent 163-kD fragment. The caspase substrate PARP was
also cleaved at this time point, generating an 89-kD frag-
ment (see Fig. 4 a, lane 3).
 
Caspases-2, -3, and -7 Cleave Golgin-160 In Vitro and 
Generate Distinct Fragments
 
To elucidate whether golgin-160 is directly cleaved by
caspases, we expressed [
 
35
 
S]methionine-labeled golgin-160
using IVTT and incubated the labeled golgin-160 with pu-
rified caspases in vitro. Cleavage reactions were per-
formed using subsaturating substrate concentrations, and
optimal cleavage conditions for the individual caspases
(Garcia-Calvo et al., 1999). Caspases-2, -3, and -7 all
cleaved golgin-160 efficiently (Fig. 3), with catalytic con-
stant (
 
k
 
cat
 
/
 
K
 
m
 
) values of 3.3
 
 3
 
 10
 
4
 
 M
 
2
 
1
 
s
 
2
 
1
 
 for caspase-2,
1.0 
 
3
 
 10
 
5
 
 M
 
2
 
1
 
s
 
2
 
1
 
 for caspase-3, and 2.6 
 
3
 
 10
 
4
 
 M
 
2
 
1
 
s
 
2
 
1
 
 for
caspase-7. Interestingly, cleavage by the different caspases
gave rise to unique fragments of golgin-160 in each case
(note that intact golgin-160 migrates at 170 kD): cas-
pase-2 generated a predominant fragment at 163 kD
(p163), and another at 140 kD (p140) (Fig. 3 a, lane 2);
caspase-3 generated a predominant fragment at 155 kD
Figure 1. Caspase-2 is local-
ized to the nucleus and Golgi
in HeLa cells. HeLa cells
(a–f) or HeLa cells stably
expressing GFP-golgin-160
(g–i) were fixed, permeabi-
lized, and double-labeled with
anti–caspase-2 (a, d, and g)
and antigiantin (b and e) or
anti-GFP (h). The stained
cells were examined by con-
focal immunofluorescence
microscopy. When red
(caspase-2) and green (gian-
tin or GFP) images were
merged, overlapping red and
green pixels appeared or-
ange/yellow (c, f, and i). An
identical caspase-2 staining
pattern was observed using
several different anti–cas-
pase-2 antibodies: affinity-
purified MF386, a polyclonal
rabbit antiserum raised against
the large subunit of caspase-2
(a–c); sc-623, a polyclonal rab-
bit antiserum raised against
an NH2-terminal peptide of
caspase-2 precursor (d–f); and
anti-ICH-1L, an mAb raised
against a peptide encompass-
ing residues 225–401 of cas-
pase-2 (g–i). MF388, a second
rabbit antiserum raised against
the large subunit of caspase-2,
also showed identical stain-
ing (data not shown). The ex-
periments were repeated on
11 (a–c), 5 (d–f), or 3 (g–i)
separate occasions with iden-
tical results. Bars: (a–c and
g-i) 10 mm; 25 mm (d–f). 
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(p155), as well as p140 (Fig 3 b, lane 2); and caspase-7 gen-
erated predominantly the p140 fragment (Fig. 3 c, lane 2).
 
Identification of Caspase Cleavage Sites in Golgin-160
 
To determine the sites at which caspases-2, -3, and -7
cleave golgin-160, we generated several mutants of golgin-
160 in which P
 
1
 
 aspartic acid residues at potential caspase
cleavage sites were substituted with alanine, and we used
these as substrates in cleavage assays in vitro. Sites were
chosen based on the approximate sizes of the fragments
observed in vitro, and the optimal tetrapeptide recogni-
tion motifs for individual proteases, recently defined using
a combinatorial tetrapeptide library (Thornberry et al.,
1997). The caspase-2 cleavage site in golgin-160 was identi-
fied as ESPD
 
59
 
G. A mutation of aspartic acid to alanine at
 
amino acid position 59 (D59A) specifically abolished the
unique p163 fragment generated by caspase-2 (Fig. 3 a,
lane 3), whereas cleavages of the D59A mutant with
caspases-3 and -7 were unchanged from wild-type golgin-
160 (data not shown). The unique caspase-3 cleavage site
was identified as CSTD
 
139
 
S using a D139A mutant for
cleavage by caspase-3 in vitro. The p155 fragment gener-
ated by caspase-3 cleavage of wild-type golgin-160 was ab-
sent in the D139A mutant (Fig. 3 b, lane 3). Cleavages of
D139A by caspases-2 and -7 were identical to those of
wild-type golgin-160 by these proteases (Fig. 3 a, lane 5,
and c, lane 3), demonstrating that CSTD
 
139
 
 is a site unique
for caspase-3. Interestingly, this is the first substrate for
caspase-3 that has cysteine in the P
 
4
 
 position. The caspase-7
cleavage site was identified as SEVD
 
311
 
G. The p140 frag-
ment of golgin-160 generated from in vitro cleavages of
IVTT-golgin-160 with caspases-2, -3, and -7 was absent
with the D311A mutant (Fig. 3, a–c, lane 4). Although this
site was not unique to caspase-7, it was most efficiently
cleaved by this protease. Thus, although SEVD
 
311
 
G is
shared as a cleavage site for caspases-2, -3, and -7, golgin-
160 also contains unique cleavage sites for caspases-2 and
-3. The cleavage data are summarized in Fig. 3 d.
 
In Vivo Cleavage of Golgin-160
 
Given the observation that golgin-160 can be cleaved by
caspases-2, -3, and -7 at different sites in vitro, we sought
to ascertain whether these protease cleavages, particularly
caspase-2 cleavage, also occur in vivo. The fact that there
is a unique caspase-2 cleavage site that is not cleaved by
the other Group II caspases enabled us to use golgin-160
as a tool to probe caspase-2 activity in vivo. To study the
cleavage fragments of golgin-160 generated during apop-
tosis, lysates of apoptotic HeLa cells were immunoblotted
with rabbit anti–golgin-160 antiserum recognizing an in-
ternal epitope (peptide comprising amino acids 649–662)
immediately after the NH
 
2
 
-terminal coiled-coil domain. A
single species of 170 kD was recognized in untreated cells
(Fig. 4 a, lane 1), whereas lysates from cells treated with
staurosporine showed time-dependent generation of p163
and p140 (Fig. 4 a, lanes 2–5). This p163 fragment de-
creased at later time points, and was associated with a con-
comitant increase in the p140 fragment. Maximum levels
of the p163 fragment were reached 
 
z
 
2 h before p140, indi-
cating that these events are kinetically distinct (Fig. 4, a
and b). The kinetics of generation of the p140 fragment of
golgin-160 closely approximates that of the 89-kD frag-
ment of PARP (Fig. 4 b), which is generated by caspases-3
and -7 (Nicholson and Thornberry, 1997; Salvesen and
Dixit, 1997). The p163 fragment was not recognized by an-
tibodies recognizing the extreme NH
 
2
 
 terminus of golgin-
160 (data not shown), confirming that this fragment lacks
the NH
 
2
 
-terminal 7 kD of the protein.
To prove that this p163 fragment is indeed generated by
cleavage at the unique caspase-2 site, we generated two
GFP fusion constructs: one with GFP fused to the NH
 
2
 
 ter-
minus of the wild-type golgin-160 coding region, and the
other with GFP fused to the golgin-160(D59A) mutant.
Stable HeLa lines were generated from these constructs,
and localization studies showed that both GFP-golgin-160
and GFP-golgin-160(D59A) localized appropriately to the
Figure 2. Golgin-160 is cleaved dur-
ing apoptosis. HeLa cells were incu-
bated for 2 h with 1 mm staurospo-
rine. Lysates from control and
treated cells were run on a 7.5%
SDS-PAGE and immunoblotted
with rabbit anti–golgin-160 antise-
rum. 70 mg of lysate was loaded in
each lane. Results are representa-
tive of three separate experiments.
Figure 3. Caspases-2, -3, and -7 cleave golgin-160 in vitro at
unique sites and generate distinct fragments. [35S]methionine-
labeled golgin-160 was expressed using IVTT, and was incubated
for 1 h at 378C with purified caspases-2, -3, or -7. Intact and
cleaved golgin-160 were detected by autoradiography. (a) Cleav-
age with caspase-2 generated a predominant fragment of 163 kD
and another of 140 kD. Mutation of aspartic acid to alanine at the
amino acid position 59 (D59A) specifically abolished the genera-
tion of the unique 163-kD caspase-2–generated fragment, and the
D311A mutation abolished generation of the p140 fragment. (b)
Caspase-3 cleaved golgin-160 to generate a predominant band of
155 kD and another of 140 kD. The unique p155 fragment was
absent in the D139A mutant, and the p140 fragment was absent
in the D311A mutant. (c) Cleavage of golgin-160 with caspase-7
generated a single fragment of 140 kD, which was absent in the
D311A mutant. (d) Schematic depiction of cleavage of golgin-160
in vitro by caspases-2, -3, and -7. These results are representative
of four separate experiments. 
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Golgi complex (Fig. 5). These HeLa cells were induced to
undergo apoptosis by treatment with staurosporine, and
the lysates were immunoblotted with anti-GFP to identify
the NH
 
2
 
-terminal golgin-160 cleavage fragments (Fig. 6 a).
Lysates from both sets of untreated cells showed an intact
band at 200 kD (the predicted size of golgin-160 fused to
30 kD GFP; Fig. 6 a, lanes 1 and 3). Interestingly, GFP-
golgin-160(D59A) migrated slightly more slowly than
wild-type GFP-golgin-160 because of the more extensive
phosphorylation of the mutant protein (data not shown).
Upon induction of apoptosis by staurosporine, the intact
wild-type GFP-golgin-160 fusion protein was cleaved, gen-
erating a new band of 38 kD (p38; Fig. 6 a, lane 2). There
was also a slight increase in a 47-kD band (p47), present at
very low levels in untreated cells, which comigrated with
the unique fragment seen when caspase-3 was added to
lysates of transfected cells (data not shown). The p38
fragment was absent in lysates from the GFP-golgin-160
(D59A) cells treated with staurosporine, which showed a
concomitant increase in the level of p47 (Fig. 6 a, lane 4).
In both stable lines, treatment with staurosporine resulted
in the characteristic cleavage of other caspase substrates,
including NuMa, PARP, and U1-70 kD (data not shown).
For a more sensitive assessment of the time course of
GFP-golgin-160 cleavage during apoptosis, immunopre-
cipitation analysis of 
 
35
 
S-labeled lysates from stable cell
lines was also performed. Levels of intact GFP-golgin-160
decreased in staurosporine-treated cells; this was accom-
panied by an increase in a p38 fragment (Fig. 6 b, wt). In
contrast, this p38 fragment was absent in D59A mutants,
and a single fragment of 47 kD was immunoprecipitated
from these cells (Fig. 6 b, D59A). Similar to the results
with endogenous golgin-160 (Fig. 4), cleavage at D59 by
caspase-2 occurred sooner after staurosporine treatment
than cleavage by caspase-3 at D139, since the p38 NH
 
2
 
-ter-
minal fragment was present as early as 2 h (Fig. 6 b, lane
3), whereas the p47 fragment appeared only after 4 h (Fig.
6 b, lane 10). Thus, the generation of this 38-kD band in
apoptotic cells, and prevention of its formation in apop-
totic cells which contain golgin-160 mutated at the unique
caspase-2 cleavage site, demonstrate that caspase-2 cleav-
age of golgin-160 occurs in vivo.
 
The NH
 
2
 
-terminal Fragment of Golgin-160 Is Released 
from Golgi Membranes after Cleavage by Caspase-2
 
We used the NH
 
2
 
-terminal anti–golgin-160 antibody to ex-
amine the distribution of the NH
 
2
 
-terminal fragment of
golgin-160 in individual cells during staurosporine-induced
apoptosis. Control and staurosporine-treated HeLa cells
were double-stained with antigiantin and anti–golgin-
160(N), and were examined by confocal immunofluores-
cence microscopy (Fig. 7). While control cells showed
colocalization of golgin-160 and giantin (Fig. 7 d), 90% of
the apoptotic cells in the staurosporine-treated sample
stained exclusively for giantin (see green staining of gi-
antin in cell with apoptotic nuclei; Fig. 7 h). These data in-
dicate that the NH
 
2
 
 terminus of golgin-160 is no longer
Golgi-associated during apoptosis, likely because of cas-
pase-induced cleavage.
 
Prevention of Golgin-160 Cleavage at the Unique 
Caspase-2 Site (D59) Delays Golgi Disintegration 
during Apoptosis
 
The Golgi complex disassembles during apoptosis (Sesso
et al., 1999), although virtually nothing is known about this
process. We noticed that after inducing apoptosis with
staurosporine, Golgi morphology changed from a tight,
juxtanuclear reticulum to a scattered appearance before fi-
nally disappearing. To determine if cleavage of golgin-160
at its unique caspase-2 site has functional relevance during
apoptosis, we compared Golgi morphology in the stable
HeLa lines expressing GFP-golgin-160 (wt) or GFP-gol-
gin-160(D59A) after inducing apoptosis. Control and stau-
rosporine-treated cells were examined by confocal immu-
nofluorescence microscopy, and the proportion of cells
with scattered Golgi complexes was quantitated (Fig. 8).
In cells expressing wt golgin-160, 44 
 
6
 
 7% of the cells ex-
hibited scattered Golgi complexes after 2.5 h of staurospo-
rine treatment, compared with 12 
 
6 
 
5% in the control
cells. In contrast, only 23 
 
6
 
 5% of the cells expressing the
mutant golgin-160 (D59A) showed scattered Golgi com-
plexes at this time point (
 
P
 
 
 
5 
 
0.0028 wt versus D59A).
This delay of Golgi disintegration in the D59A mutant in-
dicates that cleavage at the unique caspase-2 cleavage site
Figure 4. Kinetics of golgin-160 cleavage during apoptosis. (a)
HeLa lysates were made at 1, 2, 4, and 6 h after addition of 1 mm
staurosporine, and were run on a 7.5% (top) or 10% (bottom)
SDS-PAGE. 70 mg of lysate was loaded in each lane. Golgin-160
and PARP were detected by immunoblotting with anti–golgin-
160(648) or patient serum recognizing PARP, respectively. Frag-
ments are marked on the right. (b) Graph showing a decrease of
the p163 fragment concomitant with an increase in the p140 frag-
ment. Percentage of maximum fragment plotted against time in
staurosporine demonstrates that the caspase-2–generated p163
band reaches a maximum at 2 h, whereas the Group II caspase-
generated p140 band reaches its maximum at 4 h in staurospo-
rine. The kinetics of the formation of the p140 fragment of gol-
gin-160 is very similar to that for the p89 fragment of PARP.Mancini et al. Golgi-localized Caspase-2 Cleaves Golgin-160 609
plays a role in inducing the apoptotic changes in Golgi
morphology.
Discussion
Unique Golgi Distribution of Caspase-2
The distinct phenotypes observed in animals that are defi-
cient in caspase-2 or caspase-3 (group II caspase subfamily
members that share a very similar tetrapeptide substrate
specificity) suggest that unique features of individual
caspases may account for distinct regulation and special-
ized functions. In the experiments reported here, we have
demonstrated that caspase-2 has a unique subcellular dis-
tribution, and that it cleaves a macromolecular substrate at
a unique site not used by other group II caspases. Indirect
immunofluorescence microscopy, using four different anti-
bodies, revealed that endogenous caspase-2 has a Golgi
and nuclear distribution in several cell types. The nuclear
localization of GFP-tagged caspase-2 has been observed
previously; although there was also evidence of discrete
cytoplasmic staining in cells overexpressing tagged cas-
pase-2 (Colussi et al., 1998), this was not identified as
Golgi. Our studies did not demonstrate any mitochondrial
enrichment of caspase-2, under conditions where the mito-
chondrial pool of caspase-3 precursor could be clearly
demonstrated (Mancini et al., 1998; Samali et al., 1998).
This unique distribution of caspase-2, which differs mark-
edly from that previously defined for other group II
Figure 5. GFP-golgin-160
and GFP-golgin-160(D59A)
localize to the Golgi. Stable
HeLa lines expressing either
GFP-golgin-160 (GFP fused
to the NH2 terminus of wild-
type golgin-160) or GFP-gol-
gin-160(D59A) (GFP fused
to the NH2 terminus of the
D59A golgin-160 mutant)
were generated. Cells were
fixed, permeabilized, double
stained with anti-GM130
and anti-GFP, and examined
by confocal immunofluores-
cence microscopy. GM-130
antibodies were visualized
with goat anti–mouse IgG
and assigned the color red (a
and d), whereas GFP anti-
bodies were visualized with
fluorescein-conjugated goat
anti–rabbit and assigned the
color green (b and e). When images were merged, overlapping red and green pixels appeared orange/yellow (c and f). Experiments
were repeated on four separate occasions with similar results. Bars, 10 mm.
Figure 6. Golgin-160 is cleaved at D59 in vivo during staurospo-
rine-induced apoptosis. (a) The stable HeLa lines expressing
GFP-golgin-160 or GFP-golgin-160(D59A) were incubated with
1 mm staurosporine for 4 h. Lysates from untreated and treated
cells were run on 7.5% SDS-PAGE and immunoblotted with rab-
bit anti-GFP. Incubation with staurosporine resulted in a de-
crease of the intact GFP-golgin-160 molecule in both wt and
D59A mutant cells. A 38-kD fragment was detected only in stau-
rosporine-treated golgin-160 wild-type cells and not in the stau-
rosporine-treated golgin-160(D59A) mutant line, which instead
showed an increased level of the p47 fragment. (b) The GFP-gol-
gin-160 and GFP-golgin-160(D59A) stable HeLa lines were la-
beled with [35S]Met/Cys for 1 h and chased for 8 h with or without
1 mm staurosporine for different periods of time. GFP-containing
fragments of golgin-160 were immunoprecipitated with rabbit
anti-GFP from lysates from both untreated and staurosporine-
treated cells. Staurosporine treatment resulted in the disappear-
ance of intact GFP-golgin-160 in both wt (4 h) and D59A (6 h). A
p38 fragment was detected only in staurosporine-treated GFP-
golgin-160 wt cells and not in staurosporine-treated GFP-golgin-
160(D59A) mutant cells. In contrast, a single fragment at 47 kD
was immunoprecipitated from these D59A mutant cells. At the
top is a schematic depiction showing the predicted sizes of NH2-
terminal fragments of GFP-golgin-160 when cleavage occurs at
the unique caspase-2 and caspase-3 cleavage sites. Experiments
were performed on three (a) or five (b) separate occasions with
similar results.The Journal of Cell Biology, Volume 149, 2000 610
caspases, is in agreement with several recent observations,
which indicate that different caspases are enriched in
different subcellular compartments: a fraction of procas-
pase-3 has a mitochondrial location (Mancini et al., 1998;
Samali et al., 1998; Krebs et al., 1999); and procaspase-9 is
sequestered within the intermembrane space of mitochon-
dria in some cell types (Krajewski et al., 1999; Susin et al.,
1999). The available data suggest that these unique mi-
croenvironments place individual caspases in a position to
interact with a unique group of upstream activators, and to
cleave a discrete subset of downstream substrates enriched
at these sites. Identifying the adaptors that interact with
Golgi-associated caspase-2, and determining what role
these adaptor molecules have in targeting or activating
Golgi-associated caspase-2 is of high priority.
Caspase-2 Is Responsible for Efficient Cleavage of 
Golgin-160 at a Unique Site
To date, no substrates of caspase-2, other than procas-
pase-2 itself (Harvey et al., 1996), have been identified.
Studies to define potential substrates for caspase-2 at the
Golgi complex were facilitated by the observation that nu-
merous autoantigens targeted in systemic autoimmune
diseases are specifically cleaved by caspases during apop-
tosis (Rosen and Casciola-Rosen, 1999). Golgin-160, a
peripheral Golgi membrane-associated autoantigen, is
cleaved by caspase-2 in vitro and during apoptosis. Cas-
pases-3 and -7 also efficiently cleaved this substrate. Anal-
ysis of the preferred cleavage sites for caspases-2, -3, and
-7 revealed that in spite of the very similar specificity of
these three proteases observed using tetrapeptide sub-
strates, each protease selected a different preferred site in
golgin-160. One site (ESPD59) was uniquely susceptible to
cleavage by caspase-2, and provided an essential tool to
identify caspase-2 activity in intact cells. Using several dif-
ferent assays, we demonstrated that golgin-160 is cleaved
at the unique caspase-2 site early during apoptosis, and is
also subsequently cleaved at additional downstream sites.
The delay in Golgi disassembly upon induction of apopto-
sis by staurosporine in cells expressing a mutant golgin-160
lacking the unique caspase-2 site implies that cleavage of
golgin-160 is an important step in this process. It is possi-
ble that the cleavage of golgin-160 at D59 may play a more
critical role in specific pro-apoptotic stimuli preferentially
targeting the Golgi complex. Studies to address this issue
are presently underway.
The Golgi Complex: A Novel Apoptotic
Signaling Organelle?
Although the function of different golgin family members
is not yet fully elucidated, some members of this family
have been implicated in Golgi structure and function, par-
ticularly in vesicle traffic (Gleeson et al., 1996; Nakamura
et al., 1997; Lowe et al., 1998; Sonnichsen et al., 1998).
The fact that golgin-160 is a substrate for three different
caspases indicates that it will also be important to deter-
mine the function of golgin-160, and the consequences of
its cleavage at these different sites during apoptosis. The
Golgi complex, with its central location and essential role
in membrane traffic, is in an ideal position to sense and in-
tegrate information about the state of the cell. Interest-
ingly, several signaling proteins implicated in apoptotic
Figure 7. The NH2-terminal fragment of golgin-160 is released from Golgi membranes after cleavage by caspase-2. Untreated HeLa
cells (a–d) and HeLa cells treated with 1 mm staurosporine for 1 h (e–h) were fixed, permeabilized, and triple labeled with anti–golgin-
160(N) (a and e), which was visualized as red; antigiantin (b and f), which was visualized as green; and DAPI (c and g), which was visu-
alized as blue. Overlapping red and green pixels appear yellow (d and h). Arrow in h denotes an apoptotic cell, which no longer stains
for the NH2-terminal portion of golgin-160. These results are representative of three separate experiments. Bars, 10 mm.Mancini et al. Golgi-localized Caspase-2 Cleaves Golgin-160 611
signaling pathways are enriched at Golgi membranes, in-
cluding tumor necrosis factor receptor (TNF-R1), Fas, an
isoform of protein kinase C, PI(3) kinase, and BRUCE (a
novel ubiquitin-conjugating enzyme that contains a BIR
[baculovirus inhibitor of apoptosis] motif) (Bennett et al.,
1998; Hauser et al., 1998; Cockcroft, 1999; Jamora et al.,
1999; Jones et al., 1999). Golgi membranes are also likely
to be the site of at least some ceramide signaling (Maceyka
and Machamer, 1997), which has been implicated in the in-
duction of apoptosis (Kolesnick and Hannun, 1999). The
structure of the Golgi complex might be particularly con-
ducive to sensing small changes in the lipid composition of
the bilayer (Maceyka and Machamer, 1997; Wright, 1999).
Recent studies have highlighted the clustering at distinct
subcellular sites (e.g., mitochondria or plasma membrane)
of multiple components (receptors, adaptors, and effec-
tors) of the proteolytic machinery that initiates and exe-
cutes apoptotic cell death. Our findings that a proportion
of caspase-2 is located at the Golgi complex, and cleaves a
Golgi substrate early during apoptosis, focuses attention
on the Golgi complex as a potentially important site for
generating and transducing unique pro-apoptotic signals.
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